NCT04108897View on ClinicalTrials.gov

Analysis of the Microbiome in Rosacea

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 17, 2019

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Rosacea
Interventions
DRUG

Doxycycline

The investigators will administer doxycycline to rosacea patients according to the dose of patients' assigned study arm.

DRUG

Ivermectin Topical

1% topical ivermectin.

Trial Locations (1)

21287

Cutaneous Translational Research Program, Department of Dermatology, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER